Recursion Pharmaceuticals, Inc. (RXRX)
3.49
-0.09
(-2.51%)
USD |
NASDAQ |
Feb 13, 16:00
3.52
+0.03
(+0.86%)
After-Hours: 20:00
Recursion Pharmaceuticals Cash from Investing (Quarterly) : -2.549M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | -887.40M |
| Pfizer Inc. | -- |
| XOMA Royalty Corp. | 58.21M |
| Mirum Pharmaceuticals, Inc. | -2.227M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -117.36M |
| Cash from Financing (Quarterly) | 251.34M |
| Free Cash Flow | -450.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2631 |
| Free Cash Flow to Equity (Quarterly) | -111.90M |
| Free Cash Flow to Firm (Quarterly) | -116.77M |
| Free Cash Flow Yield | -32.19% |